First evidence for continuous circulation of hepatitis A virus subgenotype IIA in Central Africa.
Africa
Gabon
Hepatitis A virus
subgenotype IIA
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
03
01
2020
revised:
30
05
2020
accepted:
08
06
2020
pubmed:
22
6
2020
medline:
26
8
2021
entrez:
22
6
2020
Statut:
ppublish
Résumé
Although a high seroprevalence of antibodies against hepatitis A virus (HAV) has been estimated in Central Africa, the current status of both HAV infections and seroprevalence of anti-HAV antibodies remains unclear due to a paucity of surveillance data available. We conducted a serological survey during 2015-2017 in Gabon, Central Africa, and confirmed a high seroprevalence of anti-HAV antibodies in all age groups. To identify the currently circulating HAV strains and to reveal the epidemiological and genetic characteristics of the virus, we conducted molecular surveillance in a total of 1007 patients presenting febrile illness. Through HAV detection and sequencing, we identified subgenotype IIA (HAV-IIA) infections in the country throughout the year. A significant prevalence trend emerged in the young child population, presenting several infection peaks which appeared to be unrelated to dry or rainy seasons. Whole-genome sequencing and phylogenetic analyses revealed local HAV-IIA evolutionary events in Central Africa, indicating the circulation of HAV-IIA strains of a region-specific lineage. Recombination analysis of complete genome sequences revealed potential recombination events in Gabonese HAV strains. Interestingly, Gabonese HAV-IIA possibly acquired the 5'-untranslated region (5'-UTR) of the rare subgenotype HAV-IIB in recent years, suggesting the present existence of HAV-IIB in Central Africa. These findings indicate a currently stable HAV-IIA circulation in Gabon, with a high risk of infections in children aged under 5 years. Our findings will enhance the understanding of the current status of HAV infections in Central Africa and provide new insight into the molecular epidemiology and evolution of HAV genotype II.
Identifiants
pubmed: 32564517
doi: 10.1111/jvh.13348
pmc: PMC7586949
doi:
Substances chimiques
Hepatitis A Antibodies
0
Banques de données
GENBANK
['MH577314', 'AY644676', 'K02990', 'X75215', 'M14707', 'M20273', 'AY644670', 'AB279732', 'AB279735', 'LC515196', 'LC515208', 'KC632110', 'KC632113', 'KC632115', 'LC515202']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1234-1242Informations de copyright
© 2020 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Références
J Clin Virol. 2005 Feb;32(2):128-36
pubmed: 15653415
Virus Res. 2007 Jun;126(1-2):116-27
pubmed: 17376556
Int J Infect Dis. 2020 Feb;91:129-136
pubmed: 31821892
Int J Health Geogr. 2011 Oct 18;10:57
pubmed: 22008459
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):770-775
pubmed: 28074040
J Viral Hepat. 2020 Nov;27(11):1234-1242
pubmed: 32564517
Infect Genet Evol. 2014 Jan;21:227-43
pubmed: 24200587
J Hepatol. 2017 Sep 5;:
pubmed: 28887164
Virology. 2003 Jun 20;311(1):51-9
pubmed: 12832202
J Gen Virol. 2002 Jan;83(Pt 1):53-60
pubmed: 11752700
World J Hepatol. 2012 Mar 27;4(3):68-73
pubmed: 22489258
PLoS Biol. 2019 Apr 30;17(4):e3000229
pubmed: 31039149
Vaccine. 2010 Sep 24;28(41):6653-7
pubmed: 20723630
J Virol. 1992 Apr;66(4):2208-16
pubmed: 1312628
Virus Genes. 2010 Apr;40(2):222-4
pubmed: 20012679
J Med Virol. 2006 Aug;78(8):1015-24
pubmed: 16789007
mSphere. 2019 Jan 23;4(1):
pubmed: 30674646
EBioMedicine. 2019 Jan;39:348-357
pubmed: 30472089
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Med Virol. 2012 May;84(5):728-32
pubmed: 22431020
PLoS One. 2013 Nov 06;8(11):e74546
pubmed: 24223112
J Gen Virol. 2004 Oct;85(Pt 10):2943-2952
pubmed: 15448357
Appl Environ Microbiol. 2006 Jun;72(6):3846-55
pubmed: 16751488
J Clin Microbiol. 2010 Sep;48(9):3306-15
pubmed: 20592136
Virus Res. 2011 Jan;155(1):316-24
pubmed: 21056065